CVS Health Corp (CVS) Position Raised by FDx Advisors Inc.

FDx Advisors Inc. boosted its stake in CVS Health Corp (NYSE:CVS) by 77.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 63,320 shares of the pharmacy operator’s stock after purchasing an additional 27,736 shares during the quarter. FDx Advisors Inc.’s holdings in CVS Health were worth $4,149,000 as of its most recent filing with the SEC.

Other institutional investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its position in CVS Health by 1.7% during the third quarter. Vanguard Group Inc. now owns 84,873,814 shares of the pharmacy operator’s stock valued at $6,681,267,000 after buying an additional 1,445,887 shares in the last quarter. Vanguard Group Inc lifted its position in CVS Health by 1.7% during the third quarter. Vanguard Group Inc now owns 84,873,814 shares of the pharmacy operator’s stock valued at $6,681,267,000 after buying an additional 1,445,887 shares in the last quarter. BlackRock Inc. lifted its position in CVS Health by 2.8% during the third quarter. BlackRock Inc. now owns 76,197,017 shares of the pharmacy operator’s stock valued at $5,998,231,000 after buying an additional 2,061,915 shares in the last quarter. FMR LLC lifted its position in CVS Health by 4.3% during the third quarter. FMR LLC now owns 30,069,260 shares of the pharmacy operator’s stock valued at $2,367,052,000 after buying an additional 1,250,473 shares in the last quarter. Finally, Oregon Public Employees Retirement Fund lifted its position in CVS Health by 6,858.5% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 25,089,377 shares of the pharmacy operator’s stock valued at $383,000 after buying an additional 24,728,818 shares in the last quarter. Hedge funds and other institutional investors own 84.55% of the company’s stock.

A number of research analysts have weighed in on the stock. Sanford C. Bernstein assumed coverage on shares of CVS Health in a research report on Tuesday, March 12th. They set an “outperform” rating and a $76.00 price target on the stock. Citigroup reduced their price target on shares of CVS Health from $94.00 to $68.00 and set a “buy” rating on the stock in a research report on Wednesday, March 6th. ValuEngine cut shares of CVS Health from a “sell” rating to a “strong sell” rating in a research report on Thursday, February 28th. Argus reduced their price target on shares of CVS Health from $100.00 to $80.00 and set a “positive” rating on the stock in a research report on Monday, February 25th. Finally, Morgan Stanley set a $92.00 price target on shares of CVS Health and gave the company a “buy” rating in a research report on Friday, February 22nd. One research analyst has rated the stock with a sell rating, three have issued a hold rating and fifteen have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $84.18.

NYSE CVS opened at $55.60 on Friday. CVS Health Corp has a 52 week low of $51.93 and a 52 week high of $82.15. The company has a debt-to-equity ratio of 1.22, a quick ratio of 0.65 and a current ratio of 1.03. The firm has a market cap of $70.89 billion, a PE ratio of 7.85, a PEG ratio of 1.06 and a beta of 0.95.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, February 20th. The pharmacy operator reported $2.14 EPS for the quarter, topping analysts’ consensus estimates of $2.07 by $0.07. CVS Health had a negative net margin of 0.31% and a positive return on equity of 17.49%. The business had revenue of $54.42 billion for the quarter, compared to analysts’ expectations of $53.78 billion. During the same period in the previous year, the company posted $1.92 earnings per share. The business’s revenue for the quarter was up 12.5% compared to the same quarter last year. As a group, equities research analysts anticipate that CVS Health Corp will post 6.8 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, May 3rd. Stockholders of record on Tuesday, April 23rd will be given a dividend of $0.50 per share. The ex-dividend date is Monday, April 22nd. This represents a $2.00 dividend on an annualized basis and a dividend yield of 3.60%. CVS Health’s payout ratio is currently 28.25%.

In related news, insider Larry J. Merlo sold 166,368 shares of the company’s stock in a transaction on Tuesday, January 8th. The shares were sold at an average price of $69.04, for a total value of $11,486,046.72. Following the sale, the insider now directly owns 496,577 shares of the company’s stock, valued at $34,283,676.08. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Jonathan C. Roberts sold 77,639 shares of the company’s stock in a transaction on Friday, February 1st. The shares were sold at an average price of $64.54, for a total transaction of $5,010,821.06. The disclosure for this sale can be found here. Over the last ninety days, insiders purchased 23,600 shares of company stock worth $1,270,896 and sold 412,039 shares worth $27,326,012. Corporate insiders own 0.53% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “CVS Health Corp (CVS) Position Raised by FDx Advisors Inc.” was first published by American Banking News and is the property of of American Banking News. If you are accessing this story on another site, it was stolen and reposted in violation of US & international trademark and copyright law. The original version of this story can be read at https://www.americanbankingnews.com/2019/03/17/cvs-health-corp-cvs-position-raised-by-fdx-advisors-inc.html.

CVS Health Company Profile

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

Read More: Average Daily Trade Volume – ADTV

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply